Stage III breast cancer: Is neoadjuvant
โ
James L. Frank; Donna K. McClish; Kathy S. Dawson; Harry D. Bear
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 539 KB
Optimal management of locally advanced breast cancer is controversial. Claims of superiority for neoadjuvant systemic therapy are based on comparisons with outdated historical control groups who received no chemotherapy. Between 1978 and 1987, 118 patients with locally advanced breast cancer underwe